An analysis of newly diagnosed youths in California found they had limited access to opioid-related harm reduction services.

Three distributors and a drugmaker may avert the first federal trial over their role in the U.S. opioid crisis.

The risks are lower than ever—and could save patients months on organ waitlists.

The drug can quickly reverse opioid-driven overdoses.

A recent opinion piece in the Columbia Journalism Review argues that the distinction matters.

The CDC has called for treatment of opioid use disorder to include screening for hepatitis C and referral to care and treatment.

The FDA and the DEA issued joint warning letters to several websites telling them to stop or face severe legal consequences.

Judge’s ruling may pave the way for opening the nation’s first supervised overdose prevention facility.

The opioid epidemic is principally responsible for a recent increase in infective endocarditis in the United States.

Efforts to control viral hepatitis are falling behind, in part because of the growing opioid epidemic and homelessness crisis.